Healthcare Value Capital, LLC
Follow13F filer, CIK 1458461, Woodcliff Lake, NJ
Healthcare Value Capital, LLC reported $59,453,000 across 26 holdings for the quarter ended 2020-03-31, in a 13F-HR filed 2020-05-15. Its ten largest share positions make up 72.25% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-20-003506
- Period
- 2020-03-31
- Reported value
- $59.5M
- Holdings
- 26
- Top 10 weight
- 72.25%
- New
- 13
- Sold out
- 3
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| INVESCO QQQ TRUST SERIES 1new | +150,000 | $3.62M |
| AZNnew | +75,000 | $3.35M |
| LABORATORY CRP OF AMER HLDGSnew | +25,000 | $3.16M |
| JAZZnew | +30,000 | $2.99M |
| ALEXION PHARMACEUTICALS INCnew | +30,000 | $2.69M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| VKTXexited | -250,000 | -$2M |
| GILDreduced | -20,000 | -$1.5M |
| CVSreduced | -25,000 | -$1.48M |
| FOAMIX PHARMACEUTICALS LTDexited | -350,000 | -$1.17M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2020
Share positions as resolved from 13F-HR 0000919574-20-003506, largest first. % of portfolio is the value over $47,240,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABBVABBVIE INC | 50,000 | $3.81M | 8.07% | 0 | Timeline | ||
| GLAXOSMITHKLINE PLC-ADRGLAXOSMITHKLINE PLC-ADR | 100,000 | $3.79M | 8.02% | 0 | |||
| GILDGILEAD SCIENCES INC | 50,000 | $3.74M | 7.91% | -20,000 | Timeline | ||
| INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1 | 150,000 | $3.62M | 7.66% | new | |||
| CAHCARDINAL HEALTH INC | 75,000 | $3.6M | 7.61% | +40,000 | Timeline | ||
| MCKMCKESSON CORP | 25,000 | $3.38M | 7.16% | +15,000 | Timeline | ||
| AZNASTRAZENECA PLC-SPONS ADR | 75,000 | $3.35M | 7.09% | new | Timeline | ||
| LABORATORY CRP OF AMER HLDGSLABORATORY CRP OF AMER HLDGS | 25,000 | $3.16M | 6.69% | new | |||
| JAZZJAZZ PHARMACEUTICALS PLC | 30,000 | $2.99M | 6.33% | new | Timeline | ||
| ALEXION PHARMACEUTICALS INCALEXION PHARMACEUTICALS INC | 30,000 | $2.69M | 5.7% | new | |||
| CORCENCORA INC | 30,000 | $2.65M | 5.62% | +10,000 | Timeline | ||
| TYME TECHNOLOGIES INC COMTYME TECHNOLOGIES INC COM | 2,175,000 | $2.39M | 5.07% | 0 | |||
| MENLO THERAPEUTICS INCMENLO THERAPEUTICS INC | 850,000 | $2.28M | 4.82% | new | |||
| CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INC | 250,000 | $1.59M | 3.37% | +100,000 | |||
| CVSCVS HEALTH CORP | 25,000 | $1.48M | 3.14% | -25,000 | Timeline | ||
| ANTARES PHARMA INCANTARES PHARMA INC | 500,000 | $1.18M | 2.5% | +200,000 | |||
| WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INC | 25,000 | $1.14M | 2.42% | new | |||
| GREENLANE HLDGS INCGREENLANE HLDGS INC | 225,000 | $387K | 0.82% | +50,000 |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| GILDGILEAD SCIENCES INC COM | call | 50,000 | $3.74M | new |
| SPXLDIREXION SHARES ETF TRUST DA 500 BU 3X ETF | call | 120,000 | $3.13M | new |
| INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1 ULTRAPRO SHORT S | call | 75,000 | $1.81M | new |
| PROSHARES TR ULTSH NASD BIOTPROSHARES TR ULTSH NASD BIOT CEF | call | 75,000 | $1.06M | new |
| AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEW | call | 200,000 | $800K | new |
| CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INC COM | call | 100,000 | $636K | 0 |
| ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INC COM | call | 200,000 | $578K | 0 |
| VKTXVIKING THERAPEUTICS INC COM | call | 100,000 | $468K | new |
Sold out in Q1 2020
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| VKTXVIKING THERAPEUTICS INC | 250,000 | $2M | shares |
| FOAMIX PHARMACEUTICALS LTDFOAMIX PHARMACEUTICALS LTD | 350,000 | $1.17M | shares |
| FOAMIX PHARMACEUTICALS LTDFOAMIX PHARMACEUTICALS LTD | 50,000 | $167K | call |
How Q1 2020 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-20-003506 | base | 2020-05-15 | acceptance time not in the bulk data set |